ArticleEndocrine2021

Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant.

Sabrina Chiloiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.